Inadequate response to diet
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00381 | Amlodipine | A calcium channel blocker used to treat hypertension and angina. |
| DB01076 | Atorvastatin | An HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular disease including myocardial infarction and stroke. |
| DB03756 | Doconexent | An omega 3 fatty acid used in a variety of nutritional supplements to support central nervous system and cardiovascular health. |
| DB08909 | Glycerol phenylbutyrate | A nitrogen-binding agent used to manage patients with urea cycle disorders who cannot be sufficiently managed amino acid supplementation and/or dietary restrictions. |
| DB00627 | Niacin | A B vitamin used to treat hypertriglyceridemia and pellagra. |
| DB00175 | Pravastatin | An HMG-CoA reductase inhibitor used to lower lipid levels and to reduce the risk of cardiovascular events, including myocardial infarction and stroke. |
| DB15067 | Volanesorsen | An antisense oligonucleotide indicated to treat familial chylomicronemia. |
| Drug | Drug Name | Phase | Status | Count |
|---|